GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
74.99
+0.50 (0.67%)
Oct 8, 2025, 3:53 PM EDT - Market open
GEHC Stock Forecast
Stock Price Forecast
The 7 analysts that cover GEHC stock have a consensus rating of "Buy" and an average price target of $84.14, which forecasts a 12.20% increase in the stock price over the next year. The lowest target is $73 and the highest is $103.
Price Target: $84.14 (+12.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GEHC stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $93 → $83 | Strong Buy → Hold | Downgrades | $93 → $83 | +10.68% | Oct 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $89 → $93 | Strong Buy | Maintains | $89 → $93 | +24.02% | Jul 31, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $78 → $74 | Hold | Maintains | $78 → $74 | -1.32% | Jul 31, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $86 → $89 | Strong Buy | Maintains | $86 → $89 | +18.68% | Jul 9, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $86 → $78 | Hold | Maintains | $86 → $78 | +4.01% | May 6, 2025 |
Financial Forecast
Revenue This Year
20.86B
from 19.67B
Increased by 6.03%
Revenue Next Year
21.82B
from 20.86B
Increased by 4.61%
EPS This Year
4.61
from 4.34
Increased by 6.22%
EPS Next Year
5.04
from 4.61
Increased by 9.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6B | 22.8B | |||
| Avg | 20.9B | 21.8B | |||
| Low | 19.8B | 20.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.9% | 9.5% | |||
| Avg | 6.0% | 4.6% | |||
| Low | 0.9% | -1.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.78 | 5.39 | |||
| Avg | 4.61 | 5.04 | |||
| Low | 4.39 | 4.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.1% | 16.8% | |||
| Avg | 6.2% | 9.4% | |||
| Low | 1.2% | 1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.